BCM-15171 | 5035+ | Infiltrating ductular carcinoma (8521/3) | Negative | Negative | Positive | Negative | Negative | Positive | Wild Type | Wild Type | IV | G3 (Poorly Differentiated) | Distant Metastasis | 30.18 | White,Hispanic or Latino | No | Ado-Trastuzumab Emtansine,Capecitabine,Docetaxel,Fam-trastuzumab deruxtecan-nxki,Paclitaxel,Pertuzumab,Trastuzumab |
HCI-001 | Y0ACP5+ | Infiltrating ductal carcinoma | Negative | Negative | Negative | Negative | Negative | Negative | Not Reported | Not Reported | IV | | Primary | 39.50 | White | No | Adriamycin,Doxorubicin Liposomal,Paclitaxel |
HCI-002 | 0RR2HE+ | Infiltrating ductal carcinoma | Negative | Negative | Negative | Negative | Negative | Negative | Not Reported | Not Reported | IIIA | G3 (Poorly Differentiated) | Primary | 61.00 | White | Yes | Zometa |
HCI-003 | 3BW6YS | Infiltrating ductal carcinoma | Positive | Positive | Negative | Positive | Positive | Negative | Not Reported | Not Reported | IIIA | G3 (Poorly Differentiated) | Primary | 52.00 | White | Yes | Anastrazole,Carboplatin,Gemcitabine,Paclitaxel,Tamoxifen |
HCI-004 | N12K3Y | Infiltrating ductal carcinoma | Negative | Negative | Negative | Negative | Negative | Negative | Not Reported | Not Reported | IIA | | Primary | 54.83 | Hispanic or Latino | Yes | Cytoxan,Docetaxel |
HCI-005 | 79NTL6+ | Mixed carcinoma | Positive | Positive | Positive | Positive | Positive | Negative | Not Reported | Not Reported | IV | | Metastasis | 45.00 | White | No | Aromasin,Capecitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Fulvestrant,Gemcitabine,Letrozole,Liposomal Doxorubicin,Paclitaxel,Tamoxifen,Taxotere,Trastuzumab,Vinorebline,Zolendronic Acid |
HCI-006 | 79NTL6+ | Mixed carcinoma | Positive | Positive | Positive | Positive | Positive | Negative | Not Reported | Not Reported | IV | | Metastasis | 45.00 | White | No | Aromasin,Capecitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Fulvestrant,Gemcitabine,Letrozole,Liposomal Doxorubicin,Paclitaxel,Tamoxifen,Taxotere,Trastuzumab,Vinorebline,Zolendronic Acid |
HCI-007 | 79NTL6+ | Mixed carcinoma | Positive | Positive | Positive | Positive | Positive | Negative | Not Reported | Not Reported | IV | | Metastasis | 45.00 | White | No | Aromasin,Capecitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Fulvestrant,Gemcitabine,Letrozole,Liposomal Doxorubicin,Paclitaxel,Tamoxifen,Taxotere,Trastuzumab,Vinorebline,Zolendronic Acid |
HCI-009 | 779812+ | Adenocarcinoma | Negative | Negative | Negative | Negative | Negative | Negative | Not Reported | Not Reported | IV | G3 (Poorly Differentiated) | Metastasis | 42.00 | White | No | 5-Fluorouracil,Alternative Medicine,Anastrozole,Cyclophosphamide,Fulvestrant,Methotrexate,Paclitaxel,Tamoxifen,Zolendronic Acid |
HCI-010 | SUCWJ9+ | Infiltrating ductal carcinoma | Negative | Negative | Negative | Negative | Negative | Negative | Not Reported | Not Reported | IV | | Metastasis | 47.00 | White | No | Capcitabine,Cyclophosphamide,Doxetaxel,Doxorubicin,Liposomal Doxorubicin,Paclitaxel,Zolendronic Acid,supraclavicular nodes and axilla |
HCI-011 | Y0T0JD | Infiltrating ductal carcinoma | Positive | Positive | Negative | Positive | Positive | Negative | Not Reported | Not Reported | IV | | Metastasis | 58.00 | Hispanic or Latino | No | Arimidex,Capcitabine,Cyclophosphamide,Doxorubicin,Pacitaxel,chest wall and scar |
HCI-012 | 2SF730 | Infiltrating ductal carcinoma | Negative | Negative | Positive | Negative | Negative | Positive | Not Reported | Not Reported | IV | | Metastasis | 49.00 | White | No | 5-fluorouracil,Abraxane,Aldesleukin,Capecitabine,Capecitibine,Cyclophosphamide,Doxorubicin,Epirubicin,Herceptin,Interleukin 2,Lapatinab,Letrozole,Leucovarin,Methotrexate,Proleukin,Vinerolbine |
HCI-013 | B6WNCG+ | Infiltrating lobular carcinoma | Positive | Positive | Negative | Positive | Positive | Negative | Not Reported | Not Reported | IV | | Metastasis | 46.00 | White | No | Abraxane,Aromasin,Capcitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Fluorouracil,Gemcitabine,Letrozole,Leuprolide,Methotrexate,Paclitaxel,Tamoxifen,Zolendronic Acid |
HCI-013EI | B6WNCG+ | Infiltrating lobular carcinoma | Positive | Positive | Negative | Positive | Positive | Negative | Not Reported | Not Reported | IV | | Metastasis | 46.00 | White | No | Abraxane,Aromasin,Capcitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Fluorouracil,Gemcitabine,Letrozole,Leuprolide,Methotrexate,Paclitaxel,Tamoxifen,Zolendronic Acid |
HCI-015 | FENPV8+ | Infiltrating ductal carcinoma | Negative | Negative | Negative | Negative | Negative | Negative | Not Reported | Not Reported | IV | | Metastasis | 48.00 | White | No | Cyclophosphamide,Doxorubicon,Paclitaxel |